Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (22)	2/3/1998 7:30:00 PM
From: JFitnich	Read Replies (1) \| Respond to of 4974

You can add Immunogen (IMGN)to the list. BVF invested 3 MIllion. NOt sure if this was 5 percent or not. Company is very small, it must have been close. Press Release was on the 11th of Dec. Email address is in my profile. JF

To: scaram(o)uche who wrote (22)	2/3/1998 9:13:00 PM
From: Pseudo Biologist	Read Replies (2) \| Respond to of 4974

Hi Rick, Just saying hello and asking if wasn't Lampert one of the vocal institutional investors against the Arris-Sequana merger? If so, we may see a bye-bye SC 13 on ARRS/AXPH soon. PB

To: scaram(o)uche who wrote (22)	2/6/1998 9:52:00 AM
From: scaram(o)uche	Respond to of 4974

An interesting commentary on CROs (Chrysalis-relevant?)........ prnewswire.com Anyone own a CRO or looking at one? Rick

To: scaram(o)uche who wrote (22)	2/10/1998 9:42:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

[ SIBI news ] Very, very good........ TYPE: RW SEQUENCE: 1 DESCRIPTION: APPLICATION FOR WITHDRAWAL SIBIA NEUROSCIENCES, INC. 505 COAST BOULEVARD SOUTH, SUITE 300 LA JOLLA, CA 92037 February 9, 1998 VIA EDGAR TRANSMISSION Securities and Exchange Commission 450 Fifth Street, N.W. Judiciary Plaza Washington, D.C. 20549 RE: SIBIA NEUROSCIENCES, INC. REGISTRATION STATEMENT ON FORM S-1 (NO. 333-39389) APPLICATION FOR WITHDRAWAL Ladies and Gentlemen: The undersigned registrant hereby makes application, pursuant to paragraph (a) of Rule 477 under the Securities Act of 1933, as amended, to withdraw the above Registration Statement. This application is made on the grounds that, based on current market conditions, the undersigned registrant has determined that it is not advisable at this time to proceed with the proposed offering. If you should have any questions regarding this application, please contact Thomas A. Coll or Jane K. Adams of Cooley Godward LLP at (619) 550-6000. Sincerely, SIBIA NEUROSCIENCES, INC.

To: scaram(o)uche who wrote (22)	2/10/1998 10:03:00 AM
From: scaram(o)uche	Respond to of 4974

VRII also has some news out this morning, licensing adjumer technology for animal health. I have suggested, in another thread, that they should grab cash and IL-1beta, as an adjuvant, from CIST. FDA would not embrace this concept without intense scrutiny, however. Nonetheless, I feel that 20 years of research tells us that a little controlled inflammation is a route to effective immunization. Nobody seems willing to touch this concept with a 10 foot pole....